肾移植受者侵袭性曲霉病的危险因素与结局:美国肾脏数据系统的病例对照研究
基于美国肾脏数据系统1998至2017年肾移植患者,开展回顾性病例对照研究,将359例侵袭性曲霉病患者与1436例匹配未感染对照按1:4比较。侵袭性曲霉病是1年死亡率的强独立预测因子(aHR 5.02,95%CI 3.58-7.04,P<.001),并与1年移植物失功相关(aHR 3.37,95%CI 1.96-5.77,P<.001)。
要点
- 侵袭性曲霉病诊断距肾移植中位时间22.5个月(四分位距5.4-85.2个月)。
- 危险因素包括黑种人/非裔美国人种族、移植前血液透析时长、较高Elixhauser合并症指数评分、体重减轻、慢性肺病、移植后早期血液透析需求及巨细胞病毒感染史。
- 活体供肾对侵袭性曲霉病具有保护作用;侵袭性曲霉病与1年死亡率(aHR 5.02)及1年移植物失功(aHR 3.37)相关。
核心结论
- 研究结果强调及时移植以降低移植后侵袭性曲霉病风险的重要性,个体化预防策略对降低死亡率和移植物失功至关重要。
研究设计与样本
- 利用美国肾脏数据系统数据库,对1998年至2017年接受肾移植的患者进行回顾性病例对照研究。
- 将359例侵袭性曲霉病患者与1436例未感染对照按1:4匹配,采用条件logistic回归分析危险因素,采用Cox回归分析侵袭性曲霉病对死亡率和死亡删失移植物失功的影响。
主要发现
- 侵袭性曲霉病诊断距肾移植中位时间为22.5个月(四分位距5.4-85.2个月)。
- 侵袭性曲霉病危险因素包括黑种人/非裔美国人种族、移植前血液透析时长、较高Elixhauser合并症指数评分、体重减轻、慢性肺病、移植后早期血液透析需求及巨细胞病毒感染史。
- 接受活体供肾对侵袭性曲霉病具有保护作用。
- 侵袭性曲霉病是1年死亡率的强独立预测因子(aHR 5.02,95%CI 3.58-7.04,P<.001)。
- 侵袭性曲霉病与1年移植物失功相关(aHR 3.37,95%CI 1.96-5.77,P<.001)。
临床怎么用
- 原文结论强调及时移植以降低移植后侵袭性曲霉病风险的重要性,并指出个体化预防策略对降低死亡率和移植物失功至关重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Kidney transplant recipients are at increased risk for invasive aspergillosis (IA), a disease with poor outcomes and substantial economic burden. We aimed to determine risk factors for posttransplant IA by using a national database and to assess the association of IA with mortality and allograft failure. METHODS: Using the United States Renal Data System database, we performed a retrospective case-control study of patients who underwent kidney transplant from 1998 through 2017. To evaluate risk factors for IA, we performed conditional logistic regression analysis by comparing characteristics between IA-infected patients and their matched uninfected controls. We performed Cox regression analysis to evaluate the effects of IA on mortality and death-censored allograft failure. RESULTS: We matched 359 patients with IA to 1436 uninfected controls (1:4). IA was diagnosed at a median of 22.5 months (interquartile range, 5.4-85.2 months) after kidney transplant. Risk factors for IA were Black/African American race, duration of pretransplant hemodialysis, higher Elixhauser Comorbidity Index score, weight loss, chronic pulmonary disease, need for early posttransplant hemodialysis, and a history of cytomegalovirus infection. Receiving an allograft from a living donor was protective against IA. IA was a strong independent predictor of 1-year mortality (adjusted hazard ratio [aHR], 5.02 [95% confidence interval {CI}, 3.58-7.04], P < .001). Additionally, IA was associated with 1-year allograft failure (aHR, 3.37 [95% CI, 1.96-5.77], P < .001). CONCLUSIONS: Our findings emphasize the importance of timely transplant to mitigate the risk of posttransplant IA. An individualized approach to disease prevention is essential to decrease mortality and allograft failure.
引用
- Friedman DZP, Johnson BK, Beam E, et al. Risk Factors and Outcomes of Invasive Aspergillosis in Kidney Transplant Recipients: A Case-Control Study of United States Renal Data System Data. Clin Infect Dis. 2023. PMID: 36516420. doi:10.1093/cid/ciac927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。